Kyowa Hakko USA is a global specialty fermentation company from Japan that operates as the North & South American office for parent companies Kyowa Hakko Bio Co., Ltd. and Kirin Holdings Company, Limited. Established in 1969, it holds a dominant position as an international health ingredients manufacturer and a leader in the biotechnology, manufacturing, nutrition, pharmaceutical, wellness, and beauty industries. With its headquarters in the United States, Kyowa Hakko Bio is renowned for its pioneering work in the development and application of fermentation technology. The company maintains a strong focus on research, continually developing innovative products and enforcing rigorous quality management practices. As of now, there is no public information available regarding its last investment and the associated investors.
There is no investment information
No recent news or press coverage available for Kyowa Hakko USA.